FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I: 
, or pharmaceutically acceptable salts thereof. Value of radicals is given in the claims. Also disclosed are a series of specific compounds, a pharmaceutical composition, and the use of a compound of formula I.
EFFECT: compounds are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and therefore can be used in the treatment of a disease or disorder mediated by Trk receptors.
18 cl, 2 tbl, 218 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
| BRUTON'S TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619465C2 |
| INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
| IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
| HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743360C2 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| [1,8]NAPHTHYRIDINE DERIVATIVES, USEFUL AS INHIBITORS OF HCV VIRUS REPLICATION | 2006 |
|
RU2467007C2 |
| 3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
| SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS | 2015 |
|
RU2695649C2 |
| PYRIMIDINE DERIVATIVES WITH ACTIVITY TOWARDS MCH | 2005 |
|
RU2373197C2 |
